Welcome To SFJ Pharmaceuticals Group ®
The SFJ Pharmaceuticals Group ® is a Specialty Pharma Company deploying a new business model for the clinical development and registration of pharmaceutical products.
SFJ Pharmaceuticals Group ® provides a financially advantageous and creative alternative approach to partnering. SFJ Pharmaceuticals Group can provide the strategic financing, clinical development and regulatory resources for the clinical development and approval of your products.
SFJ Pharmaceuticals Group ® is staffed with a seasoned team of professionals, with extensive experience in the clinical development and regulatory approval of pharmaceutical products on a global basis.
SFJ Pharmaceuticals Group ® has offices in the United States, Japan, Singapore and Korea with Asia specific clinical development and regulatory experts to help you develop your pharmaceutical products for Japan, China and other Asian countries.
Press Release: The SFJ Pharmaceuticals Group announces agreement with Pfizer to co-develop Dacomitnib as first-line treatment for patients with advances non-small cell cancer.
click to view the release